30 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:41 PM
Concord Drugs Ltd.

BSE

  • 58.45 1.85 (3.27%)
  • Vol: 6604
  • BSE Code: 538965
  • PREV. CLOSE
    56.60
  • OPEN PRICE
    57.10
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    0.00(0)

NSE

  • (%)
  • Vol:
  • NSE Code:
  • PREV. CLOSE
  • OPEN PRICE
  • BID PRICE (QTY.)
    ()
  • OFFER PRICE (QTY.)
    ()

Concord Drugs Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
02-Feb-201714-Feb-2017 Quarterly Results
07-Nov-201614-Nov-2016 Quarterly Results
03-Aug-201613-Aug-2016 Quarterly Results
01-Jul-201607-Jul-2016 Concord Drugs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 07, 2016, inter alia, to consider the following: - Restructuring of the Board.
08-Feb-201613-Feb-2016 Quarterly Results
04-Nov-201514-Nov-2015 Quarterly Results
30-Jul-201514-Aug-2015 Audited Results
27-May-201530-May-2015 Audited Results
30-Mar-201530-Mar-2015 The Board of Directors of the Company will be held on March 30, 2015, inter alia, to consider and approve the following: 1. Appointment of Ms. P. Chandra Kala as Woman Director. 2. Appointment of Secretarial Auditor for the financial year 2014-15. 3. Redesignation of Mr. Koni Reddy as Director & CFO.